Platinum on biotech stocks.
How Platinum is positioned for “when the music stops”
Currently, the healthcare sector exhibits many of the traits Platinum looks for. Though the space is commonly regarded as expensive, he believes US biotech stocks are currently at their cheapest level in 30 years – with the exception of during the GFC and the 2003 downturn.